Literature DB >> 27338653

Association Between Hemoglobin A1c and Surgical Morbidity in Elective Foot and Ankle Surgery.

Natalie Domek1, Katherine Dux2, Michael Pinzur2, Frances Weaver2, Thea Rogers2.   

Abstract

The current guidelines for the management of diabetes in adults have recommended strict glycemic control, with a target hemoglobin A1c of 7.0%. Increasing evidence has shown that strict glycemic control decreases the risk of developing the organ system complications associated with diabetes. Elevated hemoglobin A1c levels have been theorized as a risk factor for complications after elective foot and ankle surgery. To test this hypothesis, we reviewed the Department of Veterans Affairs national administrative and clinical databases for a 6-year period (January 2008 to December 2013). During this period, 21,854 diabetic patients had a recorded hemoglobin A1c measurement within 1 year before undergoing elective foot and ankle surgery. We then identified those patients who had experienced postoperative complications within 30 days of elective foot or ankle surgery using the International Classification of Diseases, ninth revision, codes. The complications were classified into 4 groups: infection, wound healing, mechanical failure, and cardiovascular/pulmonary. The overall 30-day postoperative complication rate was 3.2%. The most common complication was infection (42.3%), followed by mechanical failure (33.4%), cardiovascular/pulmonary (18.4%), and wound healing (5.8%). The average hemoglobin A1c of a patient who had experienced a complication was 6.29% compared with 6.11% for a patient who had not experienced 1 of the 4 complications (p < .001). Logistic regression analysis revealed that for each 1% increase in hemoglobin A1c, the odds of developing a complication increased by 5%. More significant was the 1.78 times increased risk of developing a complication for patients with neuropathy (95% confidence interval 1.45 to 2.20; p = .0001). Even more notable was the associated risk of complications after elective foot and ankle surgery for those patients with comorbid conditions. Patients demonstrated 3.08 times the risk of developing a complication when the patient had 2 to 3 identified comorbid conditions associated with diabetes mellitus (95% confidence interval 2.42 to 3.92; p = .0001). The present retrospective observational investigation has demonstrated glycemic control influences the postoperative complication rates in elective foot and ankle surgery. However, the data collected from the present study have also demonstrated that the complication rates are multifactorial. Comorbid conditions and the presence of peripheral neuropathy also play a significant role in determining a patient's risk of complications after elective foot and ankle surgery.
Copyright © 2016 American College of Foot and Ankle Surgeons. All rights reserved.

Entities:  

Keywords:  ankle; diabetes; foot; hemoglobin A1c; surgery

Mesh:

Substances:

Year:  2016        PMID: 27338653     DOI: 10.1053/j.jfas.2016.04.009

Source DB:  PubMed          Journal:  J Foot Ankle Surg        ISSN: 1067-2516            Impact factor:   1.286


  4 in total

Review 1.  Promoting Limb Salvage through Multi-Disciplinary Care of the Diabetic Patient.

Authors:  Nichol L Salvo; Mark D Walsh; Luke P Brewster
Journal:  Curr Treat Options Cardiovasc Med       Date:  2017-07

2.  Achieving a Preoperative Target HbA1c of < 69 mmol/mol in Elective Vascular and Orthopedic Surgery: A Retrospective Single Center Observational Study.

Authors:  Celina Uppal; Andrew Blanshard; Rupa Ahluwalia; Ketan Dhatariya
Journal:  Diabetes Ther       Date:  2019-08-29       Impact factor: 2.945

Review 3.  Transmetatarsal Amputation Outcomes When Utilized to Address Foot Gangrene and Infection: A Retrospective Chart Review.

Authors:  Richard C Harris; Wei Fang
Journal:  J Foot Ankle Surg       Date:  2020-08-14       Impact factor: 1.286

4.  Incidence and risk factors for surgical site infection following elective foot and ankle surgery: a retrospective study.

Authors:  Jinghong Meng; Yanbin Zhu; Yansen Li; Tao Sun; Fengqi Zhang; Shiji Qin; Haitao Zhao
Journal:  J Orthop Surg Res       Date:  2020-10-01       Impact factor: 2.359

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.